These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 22005114)

  • 21. Nuclear medicine in the detection and management of pancreatic islet-cell tumours.
    Virgolini I; Traub-Weidinger T; Decristoforo C
    Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):213-27. PubMed ID: 15763696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of patients who have endocrine gastroenteropancreatic tumors with radiolabeled somatostatin analogues.
    Kwekkeboom DJ; Teunissen JJ; Kam BL; Valkema R; de Herder WW; Krenning EP
    Hematol Oncol Clin North Am; 2007 Jun; 21(3):561-73; x. PubMed ID: 17548040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostics of neuroendocrine tumours.
    Hodolic M; Fettich J; Banti E; Chondrogiannis S; Al-Nahhas A; Rubello D
    In Vivo; 2010; 24(5):771-4. PubMed ID: 20952747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is There an Additional Value of Using Somatostatin Receptor Subtype 2a Immunohistochemistry Compared to Somatostatin Receptor Scintigraphy Uptake in Predicting Gastroenteropancreatic Neuroendocrine Tumor Response?
    van Adrichem RC; Kamp K; van Deurzen CH; Biermann K; Feelders RA; Franssen GJ; Kwekkeboom DJ; Hofland LJ; de Herder WW
    Neuroendocrinology; 2016; 103(5):560-6. PubMed ID: 26536001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
    Wiedenmann B; Bäder HM; Scherubl H; Fett U; Zimmer T; Hamm B; Koppenhagen K; Riecken EO
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):29-32. PubMed ID: 7992077
    [No Abstract]   [Full Text] [Related]  

  • 26. Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours.
    Gibril F; Jensen RT
    Dig Liver Dis; 2004 Feb; 36 Suppl 1():S106-20. PubMed ID: 15077919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide receptor radionuclide therapy with somatostatin analogues in neuroendocrine tumors.
    Giovacchini G; Nicolas G; Forrer F
    Anticancer Agents Med Chem; 2012 Jun; 12(5):526-42. PubMed ID: 22292758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors.
    Valkema R; Pauwels S; Kvols LK; Barone R; Jamar F; Bakker WH; Kwekkeboom DJ; Bouterfa H; Krenning EP
    Semin Nucl Med; 2006 Apr; 36(2):147-56. PubMed ID: 16517236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GEP-NETS update: functional localisation and scintigraphy in neuroendocrine tumours of the gastrointestinal tract and pancreas (GEP-NETs).
    de Herder WW
    Eur J Endocrinol; 2014 May; 170(5):R173-83. PubMed ID: 24723670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.
    Treglia G; Castaldi P; Rindi G; Giordano A; Rufini V
    Endocrine; 2012 Aug; 42(1):80-7. PubMed ID: 22350660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate.
    Ezziddin S; Attassi M; Yong-Hing CJ; Ahmadzadehfar H; Willinek W; Grünwald F; Guhlke S; Biersack HJ; Sabet A
    J Nucl Med; 2014 Feb; 55(2):183-90. PubMed ID: 24434296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging of neuroendocrine tumors.
    Rufini V; Calcagni ML; Baum RP
    Semin Nucl Med; 2006 Jul; 36(3):228-47. PubMed ID: 16762613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy.
    Teunissen JJ; Kwekkeboom DJ; de Jong M; Esser JP; Valkema R; Krenning EP
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):595-616. PubMed ID: 16183530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted radiotherapy with radiolabeled somatostatin analogs.
    Nicolas G; Giovacchini G; Müller-Brand J; Forrer F
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):187-204, ix-x. PubMed ID: 21349419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
    Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
    J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current status and perspectives in peptide receptor radiation therapy.
    Ansquer C; Kraeber-Bodéré F; Chatal JF
    Curr Pharm Des; 2009; 15(21):2453-62. PubMed ID: 19601842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostics and treatment of neuroendocrine tumors of the digestive tract in the light of the present standards].
    Szczeblowska D
    Pol Merkur Lekarski; 2007 May; 22(131):437-41. PubMed ID: 17679390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and staging.
    Baumann T; Rottenburger C; Nicolas G; Wild D
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):45-57. PubMed ID: 26971843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor response assessment to treatment with [177Lu-DOTA0,Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors: differential response of bone versus soft-tissue lesions.
    van Vliet EI; Hermans JJ; de Ridder MA; Teunissen JJ; Kam BL; de Krijger RR; Krenning EP; Kwekkeboom DJ
    J Nucl Med; 2012 Sep; 53(9):1359-66. PubMed ID: 22782312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy.
    Kennedy J; Chicheportiche A; Keidar Z
    Semin Nucl Med; 2022 Mar; 52(2):229-242. PubMed ID: 34911637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.